Express News | Pfizer : Leerink Partners Cuts Target Price to $28 From $31
REGISTRATION OPEN FOR THE 13th ANNUAL BUSINESS ARCHITECTURE INNOVATION SUMMIT
Guggenheim Adjusts Price Target on Pfizer to $33 From $35, Keeps Buy Rating
Is Pfizer Inc. (PFE) the Best American Dividend Stock to Buy Right Now?
The clinical results of the protein degradation combination therapy by Arvinas and Pfizer (PFE.US) are positive, with a clinical benefit rate for patients exceeding 62%.
Arvinas and Pfizer (PFE.US) today announced preliminary data from the ongoing Phase 1b clinical trial TACTIVE-U sub-study.
BofA Restarts Coverage of 11 Large-cap Biopharmas
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Ginvest : a guiltless conscience company. What do I do with my 5000 shares?
10baggerbamm OP Ginvest : that's your decision with vaccines these companies are 100% exonerated under current laws in the United States you can't sue any vaccine manufacturers now maybe that will change with Kennedy I don't know I think there should be accountability at all levels.